Role of miRNA in malignoma of the head and neck;Die Rolle von miRNA bei Kopf-Hals-Malignomen

Laryngo- Rhino- Otologie

Volumn 93, Issue 3, 2014, Pages 201-210

  Coordes, A ^a   Lenarz, M ^a   Kaufmann, A M ^a   Albers, A E ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

cancer stem cell; epithelial to mesenchymal transition; HNSCC; HPV; microRNA

Indexed keywords

MICRORNA;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CARCINOGENESIS; DISEASE COURSE; EARLY DIAGNOSIS; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; MONITORING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE;

CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; EARLY DIAGNOSIS; EPITHELIAL-MESENCHYMAL TRANSITION; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; HUMANS; INTRONS; MICRORNAS; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; ONCOGENE PROTEINS, VIRAL; OTORHINOLARYNGOLOGIC NEOPLASMS; PHENOTYPE; PROGNOSIS;

EID: 84896851909     PISSN: 09358943     EISSN: 14388685     Source Type: Journal    
DOI: 10.1055/s-0033-1363960     Document Type: Article

References (38)

1. Jones A. S., Goodyear P. W., Ghosh S. et al. Extensive neck node metastases (N3) in head and neck squamous carcinoma: is radical treatment warranted? Otolaryngol Head Neck Surg: 2011; 144 29 35
2. Pignon J. P., le Maitre A., Maillard E. et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17 346 patients. Radiother Oncol: 2009; 92 4 14
3. [Anonym] IARC Cancer Incidence in Five Continents. Vol IX 1983-2002, DOI
4. Hammarstedt L., Lindquist D., Dahlstrand H. et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer: 2006; 119 2620 2623
5. Leeman-Neill R. J., Seethala R. R., Singh S. V. et al. Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma. Cancer Prevention Research: 2011; 4 230 237
6. Wienholds E., Plasterk R. H. MicroRNA function in animal development. FEBS Letters: 2005; 579 5911 5922
7. Bourguignon L. Y., Earle C., Wong G. et al. Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells. Oncogene 31 149 160
8. Lu Z., Liu M., Stribinskis V. et al. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene: 2008; 27 4373 4379
9. Xu X., Chen Z., Zhao X. et al. MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma. Biochem Biophys Res Commun. 421 640 645
10. Babu J. M., Prathibha R., Jijith V. S. et al. A miR-centric view of head and neck cancers. Biochim Biophys Acta: 1816; 67 72
11. Lo W. L., Yu C. C., Chiou G. Y. et al. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. The Journal of pathology: 2011; 223 482 495
12. Visvader J. E., Lindeman G. J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer: 2008; 8 755 768
13. Mani S. A., Guo W., Liao M. J. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell: 2008; 133 704 715
14. Singh A., Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene: 2010; 29 4741 4751
15. Boominathan L. The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex. PLoS ONE [Electronic Resource]: 2010; 5 e10615
16. Xu J., Gimenez-Conti I. B., Cunningham J. E. et al. Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use. Cancer: 1998; 83 204 212
17. Haraf D. J., Nodzenski E., Brachman D. et al. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res: 1996; 2 755 762
18. Klussmann J. P., Gultekin E., Weissenborn S. J. et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol: 2003; 162 747 753
19. Talis A. L., Huibregtse J. M., Howley P. M. The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells. J Biol Chem: 1998; 273 6439 6445
20. Xie X., Piao L., Bullock B. N. et al. Targeting HPV16 E6-p300 interaction reactivates p53 and inhibits the tumorigenicity of HPV-positive head and neck squamous cell carcinoma. Oncogene: 2013
21. Ji Q., Hao X., Zhang M. et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PloS one: 2009; 4 e6816
22. Ji Q., Hao X., Meng Y. et al. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer: 2008; 8 266
23. Li B., Hu Y., Ye F. et al. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection. Int J Gynecol Cancer: 2010; 20 597 604
24. Martinez I., Gardiner A. S., Board K. F. et al. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene: 2008; 27 2575 2582
25. Wald A. I., Hoskins E. E., Wells S. I. et al. Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus. Head Neck 33 504 512
26. Sniezek J. C., Matheny K. E., Westfall M. D. et al. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma. Laryngoscope: 2004; 114 2063 2072
27. Lena A. M., Shalom-Feuerstein R., Rivetti di Val Cervo P. et al. miR-203 represses 'stemness' by repressing DeltaNp63. Cell Death Differ: 2008; 15 1187 1195
28. Yi R., Poy M. N., Stoffel M. et al. A skin microRNA promotes differentiation by repressing 'stemness' Nature: 2008; 452 225 229
29. Sonkoly E., Wei T., Janson P. C. et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PloS one: 2007; 2 e610
30. Feber A., Xi L., Luketich J. D. et al. MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg: 2008; 135 255 260 discussion 260
31. Iorio M. V., Visone R., Di Leva G. et al. MicroRNA signatures in human ovarian cancer. Cancer Res: 2007; 67 8699 8707
32. Kozaki K., Imoto I., Mogi S. et al. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res: 2008; 68 2094 2105
33. Yanaihara N., Caplen N., Bowman E. et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell: 2006; 9 189 198
34. Li J., Chen Y., Zhao J. et al. miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression. Cancer Lett: 2011; 304 52 59
35. Liu X., Wang C., Chen Z. et al. MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines. Biochem J: 2011; 440 23 31
36. Melar-New M., Laimins L. A. Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. J Virol: 2010; 84 5212 5221
37. He L., He X., Lim L. P. et al. A microRNA component of the p53 tumour suppressor network. Nature: 2007; 447 1130 1134
38. Chen C., Zimmermann M., Tinhofer I. et al. Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma. Cancer Lett: 2013; 338 47 56